157 results
8-K
VRDN
Viridian Therapeutics Inc
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:15am
for the quarter ended September 30, 2023.
Preliminary data from our clinical trials that we announce or publish are subject to audit and verification procedures … trials, may change as more patient data become available, and we become subject to audit and verification procedures that could result in material changes
S-3ASR
EX-4.2
nlu24gy3y
30 Nov 23
Automatic shelf registration
4:05pm
8-K
EX-10.2
ay9jei4f960k3yki
30 Oct 23
Entry into a Material Definitive Agreement
8:35am
424B5
efuw ljnzyykl79l8
18 Aug 22
Prospectus supplement for primary offering
4:41pm